OTCMKTS:HCYTD

H-CYTE (HCYTD) Stock Price, News & Analysis

$2.02
-1.98 (-49.50%)
(As of 07/11/2022)
Today's Range
$2.02
$2.77
50-Day Range
$2.02
$2.02
52-Week Range
$2.02
$77.00
Volume
400 shs
Average Volume
103 shs
Market Capitalization
$521,160.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HCYTD stock logo

About H-CYTE Stock (OTCMKTS:HCYTD)

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

HCYTD Stock Price History

HCYTD Stock News Headlines

H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5%
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
H&R Block Coupons February 2024
Hyatt Hotels Corp Class A H
H-E-B Grocery Company
10-K: H-CYTE, INC.
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
HCYT H-CYTE, Inc.
H-CYTE Completes Acquisition of Jantibody
H-CYTE Announces 1-for-1,000 Reverse Stock Split
Should You Refrigerate Peanut Butter?
H-CYTE Inc (HCYT)
H-CYTE Names Michael Yurkowsky Chief Executive Officer
See More Headlines
Receive HCYTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H-CYTE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:HCYTD
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Net Income
$-4,800,000.00
Net Margins
-450.40%
Pretax Margin
-450.40%

Debt

Sales & Book Value

Annual Sales
$1.61 million
Book Value
($31.45) per share

Miscellaneous

Free Float
244,000
Market Cap
$521,160.00
Optionable
Not Optionable
Beta
1.12
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael W. Yurkowsky (Age 50)
    CEO & Director
    Comp: $180k
  • Mr. Jeremy Daniel (Age 46)
    Chief Financial Officer
    Comp: $200k
  • Dr. Tanya Rhodes Ph.D. (Age 61)
    Chief Scientific Officer
    Comp: $252k
  • Mr. Jeffery Wright CPA (Age 39)
    CPA, Controller & Principal Accounting Officer

HCYTD Stock Analysis - Frequently Asked Questions

How have HCYTD shares performed in 2024?

H-CYTE's stock was trading at $2.02 at the start of the year. Since then, HCYTD stock has increased by 0.0% and is now trading at $2.02.
View the best growth stocks for 2024 here
.

How do I buy shares of H-CYTE?

Shares of HCYTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:HCYTD) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners